Digital Health Meetings

Pharma-DTx Partnerships can be a good strategy when they speak the same language. Apply now to join this 2 part session where you will discuss 5 key challenges and agree on 5 key recommendations around this topic with your peers.

In this innovation showcase, 3 Digital Biomarkers companies working on CNS and cognition assessment will meet 121 with 3 Pharma/Medtech/Investors to discuss mutual challenges when building successful collaborations. Seats are limited to 3  Pharma/Medtech/Investors and 3 Digital Biomarkers companies so we can pair you 1-2-1. Apply now to book your place!

Digital health’s interaction with pharma is evolving; it has to evolve. Join us in this roundtable to discuss how pharma can do digital health better in the next few years.

Digital health's interaction with pharma is evolving; it has to evolve. In this webinar, we will have a panel discussion with forefront leaders in digital health. Join now to secure your place.

Despite DTx gaining traction in terms of investment, adoption still remains a challenge, and DTx companies struggle to secure reimbursement. Apply now to join your peers as we deep dive into this topic.

Measuring patient engagement with digital health solutions is crucial to ensure the digital intervention is impactful and helps improve patient outcomes. Join this discussion to dive deeper into this topic with your peers working in this space. Seats are limited to apply now to secure your place.

Regulatory clearance and the right commercialization model for a digital health product are key components of success in this rapidly growing space. Apply now to join this Masterclass led by Jonas Albert (Digital Health Expert at fbeta) and Hans-Holger Bleß (Partner at fbeta).

Extended Reality (XR) is a powerful technology that can be used anywhere, at any time. Join HealthXL in this meeting as we discuss this topic further. Seats are limited so apply now to secure your place.

Pharma-DTx Partnerships can be a good strategy when they speak the same language. Apply now to join this 2 part session to address 5 key challenges and agree on 5 key recommendations around this topic.

Industry is from Mars. The Government is from Venus. How can digital health companies get R&D and commercialization US government funding? Apply now to join this Masterclass led by industry leaders.
‍

Whilst digital health startups in oncology have tried to build prosperous partnerships with pharma, there are no outstanding results yet, and it has proven hard to make it work. Seats are limited for this event so apply now to deep dive into this topic with your peers.

The healthcare industry is undergoing a digital transformation and extended reality (XR) technologies such as virtual reality (VR) and augmented reality (AR) are expected to play a significant role in this change in the next few years. Apply now to join this Masterclass led by Nemanja Kovačev, MedTech Expert at HTEC Group.

In this innovation showcase, 3 Digital Health companies in Oncology will meet 121 with 3 Pharma/Medtech/Investors/Healthcare Providers, to discuss mutual challenges when building successful collaborations. Apply now to join this session as seats are limited.

Due to the lack of industry-wide evidence frameworks for digital health solutions in oncology, regulators' and payers' requirements are usually the same as drugs. Join HealthXL in this meeting to deep dive into this topic.

Unlike other therapeutic areas, mental health evaluation and management can be a bit of an art, and at times relies on subjectivity in the outcomes analysis. Join this meeting to discuss this topic further with others working in this space. Places are limited so apply now to avoid disappointment.

As technology advances in all sectors (e.g. fintech, entertainment, etc), consumer behaviour changes and the expectations on user experience are higher than before. Apply now to secure your place in this meeting where you will dive deeper into this topic with your peers.

Proving clinical efficacy is one of the biggest challenges for DTx companies. Apply now to join HealthXL in this session to dive deeper into this topic with leaders in this field.

The digital health industry has seen a decline in funding in recent times, as investors have become more knowledgeable and selective to where they allocate their capital. Seats are limited so apply now to secure your place.

Millions of people worldwide suffer from autoimmune conditions such as rheumatoid arthritis (RA), psoriasis, lupus, Crohn's disease, multiple sclerosis, atopic dermatitis, to name a few. Join this meeting to deep dive into this topic in the Immunology Meeting Series. Seats are limited so apply now to secure your place.

In the past few years, digital health solutions have proven to be helpful in preventing and managing cardiometabolic diseases remotely, leading to better  health outcomes and less hospitalizations, emergency visits, and in-office visits.

Are you trying to increase adoption and use of your Digital Health solution across the UK's National Health Service? Join your peers in this meeting as they deep dive into this topic. Apply now to secure your place as seats are limited.

The drug discovery process has traditionally been costly and very time-consuming. Join this Webinar to deep dive into this topic with senior leaders in this area.

Are we entering the era of retail health and retail medicine? What role does digital health play in retail healthcare? Join HealthXL in this webinar where we will deep dive into this topic with Adam Pellegrini (former SVP Enterprise Virtual Care & Consumer Health Innovation at CVS, former VP Digital Health at Walgreens, currently CEO at Jasper Health).

Pharma companies are not risk takers, and adding a DTx to their products can be seen as a threat rather than a value-add. In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. Seats are limited so apply now to secure your space.

Getting regulatory clearance/approval for DTx can be challenging, and it requires a learning curve to define the best regulatory strategy for a specific solution. Join this Masterclass to deep dive into this topic further.

Digital health companies need to show economic evidence for their solutions, but building that evidence can be very difficult, especially for small companies that are new in the market. Join this meeting to deep dive into this topic with other senior leaders in this field.

Why is now the right time to move from DTx point solutions to platforms? How to bring this to life? Join this meeting to discuss this topic further with your peers. Apply now to secure your seat.

How can we help healthcare providers and health systems sift through the universe of digital solutions in mental health? How can digital health companies engage providers? Join this meeting to deep dive into this topic with your peers. Spaces are limited so apply now to secure your place.

It can be hard for HCPs to provide precise medical decisions in autoimmune conditions due to the patient variability and the trigger events not being fully understood. Join other senior leaders in this meeting to discuss this topic further.

Market access and adoption are huge challenges in the DTx and Pharma/Life Sciences industry. Apply now to deep dive into this topic with your peers working in this space.

Health systems have been shocked in a way that has never been seen before with the COVID-19 pandemic. Join HealthXL in this meeting to discuss this topic with your peers working in this space.

In this masterclass, we will touch on different case studies of human-centered design in digital health. Spaces are limited so apply now to secure your seat.

Many pharma companies have explored partnerships with DTx companies in the last few years, seeking for innovative technologies that add value to their products and services. Apply now to secure your place in this Digital Health meeting.

Pharma companies are not risk takers, and adding a DTx to their products can be seen as a threat rather than a value-add. In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. Seats are limited so apply now to secure your place.

While the combination of a drug with a DTx can increase the treatment value, there are many challenges when trying to fit these combinations into the pharma traditional sales model. Join this 2 part sprint to establish 5 key challenges and agree on 5 key recommendations with your peers working in this space.

‍

The connection between DTx and human coaching in mental health can weave together a more precise, personalized, and connected care experience. Apply now to join this meeting to discuss this topic further with your peers.

In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Spaces are limited so apply now to secure your place.

Are you seeking reimbursement of a DTx solution in the US? Join this Masterclass led by Mike Pace to deep dive into this topic with your peers working in this space.

Currently, there is no one-size-fits-all strategy for DTx distribution. Join HealthXL in this meeting to discuss this topic further with your peers working in this space.

Are you trying to commercialize AI-based digital health solutions in the European Union (EU)? Would you like to learn practical steps on how to navigate the EU regulations for AI in medical devices? Join us in this masterclass led by Erik Vollebregt (Partner at Axon Lawyers) to deep dive into this topic.

How do DTx products get listed on a formulary? And what happens next? Join this masterclass to hear from Mark Bini, the visionary who helped devise Evernorth's Digital Health Formulary.

‍

Are you working in digital health and looking for successful partnerships with health systems? Join this meeting to deep dive into this topic with other senior leaders in this field.

Without adoption, even the best DTx solution will have no impact. Apply now to join this meeting and discuss this topic further with your peers working in this space

DTx-Drug combinations can improve the treatment value, thus leading to better patient outcomes. Join HealthXL in this session to discuss this topic with thought leaders in this space.

While the combination of a drug with a DTx can increase the treatment value, there are many challenges when trying to fit these combinations into the pharma traditional sales model. Join this 2 part sprint to establish 5 key challenges and agree on 5 key recommendations to overcome them with your peers working in this space.

Unarguably, DTx solutions have clear benefits for patients. Join HealthXL in this 2 part meeting to establish 5 key challenges and agree on 5 key recommendation to overcome them.

The reimbursement path for digital health solutions in Europe has always been complex to navigate. Join this Masterclass led by Aymeric Perchant to deep dive into this topic.

While the number of partnerships between DTx and Pharma have grown in the past years, we haven’t seen big successes yet, and part of that could be due to bad roadmap definition and its execution. Join your peers in this meeting to discuss this topic further

In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Spaces are limited so apply now to secure your place.

In Neurodegenerative Diseases, aging is a risk factor and as the older populations grow, its prevalence increases, leading to an enormous burden on healthcare systems. Join this meeting to deep dive into this topic with other senior leaders in this field.

Are you struggling to get patients and healthcare professionals (HCPs) to adopt your digital health product? Join this meeting to deep dive into this topic with your peers working in this space.

Join us for our next HealthXL Webinar 'Metaverse in Healthcare' where we will take a deeper look at the potential the metaverse has in the healthcare space.

Oncology services have changed in recent years from the way cancer is diagnosed to how treatment is being delivered. Join other senior leaders in this session to deep dive into this topic.

Proving clinical efficacy is one of the biggest challenges for SaMD manufacturers. However, it is key to getting buy-in from stakeholders. Join this Masterclass led by Shaheen Lakhan (Chief Medical Officer, Click Therapeutics) to depp dive into this topic with other senior leaders in this area.

Unarguably, DTx solutions have clear benefits for patients. Join HealthXL in this 2 part Sprint where we will break this topic down into 5 key challenges and agre on 5 key recommendations to overcome the challenges.

There is no question that Big Tech has the capability to disrupt healthcare, though the complexity of healthcare ecosystems is not making it easy for these companies. Join this meeting to dive deeper into this topic and discuss how Big Tech is getting into digital health.

Many DTx companies target payers to get reimbursed, but very few vendors get what they are looking for. Join this meeting to deep dive into this topic with other senior leaders in this area.

‍

Real-World Data (RWD) can be highly valuable for many stakeholders in healthcare, such as pharma, MedTech, payers, or hospitals. Join this Masterclass, led by Philip Russmeyer (Founder, FITFILE) to discuss this topic further.

Cardiovascular diseases (CVD) have been at the forefront of digital health innovations. Join HealthXL in this meeting where we will focus on the use of digital health tools for the prediction of cardiovascular events.

Physician adoption is one of the keys to unlocking the revenues expected from DTx solutions. Join HealthXL in this meeting to discuss this topic with other senior leaders in this field.

‍

Regulatory clearance and the right commercialization model for a digital health product are key components of success in this rapidly growing space. Join us in this interactive masterclass led by Dr. Victor Stephani (responsible for Market Access and Chief of Staff at HelloBetter) to discuss this topic further.

In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Biomarkers partners to discuss mutual challenges they face when building successful collaborations. Seats are limited so apply now to join this session.

In a complex disease area like oncology, treatments usually cause adverse effects that compromise patients' quality of life. Join this session to discuss this topic further with your peers working in this field.

While integrating Remote Patient Monitoring programs (RPM) into health systems and hospital workflows is key to push the adoption rates, it is not an easy task. Join Part 2 of this sprint where we will continue this discussion and break this down into 5 key challenges and agree on 5 key recommendations to overcome them.

Over the last few years, partnerships between digital therapeutics (DTx) and Life Sciences companies have grown exponentially. Join HealthXL in this meeting to discuss this topic with thought leaders in this area.

Digital health solutions can track a huge amount of data points, but tracking too many different measures can make you lose focus. Join HealthXL in this meeting to discuss this with other thought leaders working in this area.

‍

In this innovation showcase, Pharma, Medtech and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Apply now to book your place in this bilateral discussion.

When the pandemic was hitting the world, venture capitalists invested more than ever in Digital Therapeutics (DTx) as the world was moving away from the traditional in-person care settings, and patients needed new ways to access care and treatments. Join HealthXL to discuss this topic with your peers working in this area.

In a world where customers are used to excellent user experience (e.g. Google, Amazon, Apple, etc.), DTx companies need to meet customers' expectations. Join other senior leaders in this session to discuss what the success metrics of patient engagement are for DTx solutions.

Are you considering clinical validation for a SaMD or SaMD/PDT+drug combination product? Join this meeting to discuss this topic further with others working in this field

As more DTx-drug combinations emerge, regulation is becoming increasingly important. Join HealthXL in this meeting to dive deeper into this topic.

Clinical trials are thoughtfully designed and implemented to ensure the right patients are involved, quality standards are strictly followed, and the endpoints selected are the right ones to show the drug’s safety and effectiveness. Join HealthXL in this discussion to dive deeper into this topic.

Digital solutions have great potential in mental health, improving care access, symptom tracking, and treatment personalization. Join HealthXL in this meeting to discuss this topic further with your peers working in this area.

‍

While integrating Remote Patient Monitoring programs (RPM) into health systems and hospital workflows is key to push the adoption rates, it is not an easy task. Join this two part session to discuss this topic further.

‍

Are you struggling to get patients and healthcare professionals (HCPs) to adopt your digital health product? Join HealthXL in this meeting to discuss this further.

Join this masterclass led by Tahir Rizvi (Head of Quality Assurance and Regulatory Affairs at Caption Health) and Armen Vidian (Digital Health Venture Capitalist) to learn more about the regulatory considerations for AI-based solutions in the US.

‍

Are you a digital therapeutics (DTx) company seeking reimbursement in the US market? Join this masterclass led by the biopharma and DTx reimbursement expert Mike Pace to dive deeper into this topic.

Are you a digital health company looking to fundraise, acquire new customers or hire key executives? If so, crafting a story that inspires, builds trust, and drives credibility is critical. 

‍

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

In this webinar with Ankita Deshpande (Head of Innovation Accelerator at Alexion Pharmaceuticals), we will deep dive into the unique opportunities and challenges of digital health in rare diseases. Register now to secure your place!

What are the best models for DTx in the US in this new reality? How will the business models change in the future? Join us in a peer-to-peer conversation where we will discuss these questions and more!

Healthcare is one of those areas that one would expect to be more human-centric, at the end of the day, what is more human than getting sick? Join HelathXL in this masterclass led by Kellee M. Franklin, PhD, Founder of Mindful Innovation Labs, and Carole Tremonti, VP Clinical Strategy at Project Cronin, where they will discuss how we can be more human-centric when creating digital health solutions for patients and the care team.

While the digital therapeutics (DTx) market is increasingly growing, it is still small compared to large players in the healthcare industry such as pharma. Join HealthXL in this peer-to-peer discussion to deep dive into this topic.

Join this meeting to take a deep dive into what the best business models will be in the next few years for virtual care companies in the diabetes space.

Are you trying to commercialize a digital therapeutics (DTx) solution in the European Union (EU)? Would you like to learn practical steps on how to navigate the European regulatory landscape? Keep reading, this masterclass is for you!

‍

The right commercialization model for a digital health product is a key component of success in this rapidly growing space. Join this masterclass led by Steven Vandeput, PhD, to discuss this topic further.

Pharma companies are huge corporations with complex operations to ensure the quality of their products and services. Join HealthXL in this meeting to deep dive into this topic with others working in this space.

The accelerated growth of the virtual care industry since the pandemic has opened many opportunities for virtual care companies. Join HealthXL in this meeting to dive deeper into this topic and discuss further with your peers working in this space.

Digital therapeutics (DTx) and drugs are very different care solutions. However, DTx are often compared to traditional pharmaceutical products because the terminology and definitions are unclear. Join this meeting to discuss this topic further with your peers.

Most digital health companies in oncology will struggle to get their products in the market on their own. Join HealthXL in this meeting to discuss the do's and don'ts when seeking partnerships for digital health companies in oncology.

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Are you trying to figure out what is the best distribution channel for your digital therapeutics (DTx) solution? Join this meeting to discuss this topic further with your peers working in this space.

Digital health companies can take different routes to market, however, finding the one that is sustainable and scalable in the long term, is not an easy task. Join this meeting to discuss this topic further with others working in this space.

What makes for a successful business model for digital companies in mental health? Join us in this fireside chat with Russell Glass, CEO at Headspace Health, where we will deep dive into the business models for digital companies in the mental health space. Register now to secure your place.

Are you targeting payers as part of your market access strategy? What do you need to know about their evidence requirements for DTx? Join HealthXL in this meeting to discuss this topic further with your peers working in this space.

Are you a digital therapeutics (DTx) start-up seeking capital? How can companies get attention from investors in an increasingly competitive industry? Join HealthXL in this meeting to discuss this topic further with others working in this space.

The definition of Digital Therapeutics (DTx) is broad, including many different solutions, making it hard to agree on the evidence generation standards. Join this meeting to dive deeper into this topic and learn from your peers working in this area.

Are you trying to get your DTx solution regulated in the US? Would you like to learn from the experiences of a real company? Join HealthXL in this masterclass led by Michelle Rubin-Onur from Blue Note Therapeutics to dive deeper into this topic

The investment case for digital health solutions is straightforward in many therapeutic areas, such as diabetes, oncology, mental health, women’s health, among others.

Join HealthXL's next webinar with Julie Murchinson, Partner at Transformation Capital, as we discuss growth and scalability strategies in digital health. Apply now to secure your place.